Zydus Lifesciences gets Health Canada approval, share price unchange
Published on: Oct. 27, 2025, 7:27 a.m. | Source: Moneycontrol
Zydus Lifesciences Share Price | The company received NOC from Health Canada to manufacture Mesalamine.
Mumbai’s Trusted Investment Experts
24+ years of financial planning, portfolio management & wealth growth.
One Partner for All Your Financial Goals
From financial planning and insurance to portfolio management and retirement solutions—get everything under one trusted roof.
Book Consultation